Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MNTek is a South Korea-based sensor technology company focused on MEMS-based sensing systems and application-specific sensor design. The company appears to operate primarily as a hardware and component developer rather than a therapeutic drug developer, with capabilities spanning ultra-thin, low-power MEMS sensor elements, hydrogen detection sensors, and pressure or biomedical sensor applications. In healthcare, MNTek has been identified as a consortium participant contributing biomedical sensor technology to support development of a renal denervation device for hypertension. Publicly available information suggests it is an active private company founded in 2009 and headquartered in Suwon, Gyeonggi-do, South Korea. Its overall profile is closer to a medtech-enabling sensor platform company than a biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MNTek.